Dantari: Funding, Investors & Team (Sep 2026)
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.
Dantari has raised $47.0M across 1 funding round on record, the most recent a Series A of $47.0M announced in Dec 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dantari Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Dantari Funding Rounds
Dantari Founders and Leadership Team
Contact details for the Dantari team: 1 of 1 has an email address on file.
Start 14-day free trial →Dantari Funding Compared to Other Biotechnology Startups
Dantari's latest round of $47.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dantari in Biotechnology and Thousand Oaks
Companies Similar to Dantari
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Dantari Funding FAQs
What does Dantari do?
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.
How much funding has Dantari raised?
Dantari has raised $47.0M across 1 round on record. The most recent is a Series A of $47.0M announced in Dec 2022.
When did Dantari last raise funding?
Dantari's most recent funding round on record is a Series A of $47.0M, announced in Dec 2022.
Who is the CEO of Dantari?
Richard Markus is listed as CEO at Dantari.
Where is Dantari headquartered?
Dantari is based in Thousand Oaks, California, United States.
How many employees does Dantari have?
Dantari is in the 11-50 employee band.
How does Dantari's funding compare to other Biotechnology startups?
Dantari's latest round of $47.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Dantari Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dantari is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.